See also this year's filing and all EDGAR filings for this company.
PDF Report 0001802768_2022_Royalty_Pharma_plc.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'XOMA Royalty Corp', 'shared_tokens': {'royalty'}}]} |
Graph
Absolute values for 0001802768, Royalty Pharma plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,878,211,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,670,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 14,631,984,000 |
| 4 | LiabilitiesCurrent | 171,250,000 |
| 5 | LiabilitiesNoncurrent | 7,096,070,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 182,826,000 |
| 9 | ResearchAndDevelopmentExpense | 200,084,000 |
| 10 | remainder_Expenses | 475,838,000 |
| 11 | remainder_Revenues | 2,289,463,000 |
| 12 | remainder_NetIncome | -189,514,000 |
| 13 | remainder_ComprehensiveNetIncome | -643,619,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,515,865,000 |
| 1 | Liabilities | 7,267,320,000 |
| 2 | Expenses | 858,748,000 |
| 3 | Revenues | 2,289,463,000 |
| 4 | StockholdersEquity | 10,248,545,000 |
| 5 | NetIncome | 1,241,201,000 |
| 6 | ComprehensiveNetIncome | 919,391,500 |
| 7 | BaseVar | 14,382,264,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.88 |
| 9 | EconomicCapitalRatio | 2.94 |
Edgar->Model Mapping
Feature Distribution
Change over Time
